Clinical Cardiology Alert – April 1, 2012
April 1, 2012
View Issues
-
Pacemaker Lead Recall
This report from a consortium of Canadian implantable cardioverter-defibrillator (ICD) implantation centers analyzed predictors of failure of the Medtronic Sprint Fidelis lead. -
New Indications for CRT
This paper reviews the recent data on the effectiveness of cardiac resynchronization therapy (CRT) in patients with milder forms of heart failure (NYHA classes 1 and 2) and revises the Heart Failure Society of America's (HFSA) 2010 Guidelines. -
Myocardial Infarction Symptom Presentation
Timely recognition and treatment of myocardial infarction (MI) are crucial if we are to achieve optimal outcomes for our patients. -
Newer is Better! New Generation DES outperform older DES and BMS
For those who perform percutaneous coronary intervention (PCI), the newer generation stents have obvious benefits during the procedure. -
Value of C-reactive Protein in Managing Cardiovascular Risk
The value of high sensitivity C-reactive protein (CRP) measurements in the management of patients at risk for cardiovascular (CV) events is controversial. -
Is a Family History of Cardiovascular Disease Valuable?
Although a routine part of a complete medical history, the value of systematically collecting family history has not been shown in controlled trials. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
Statins and diabetes risk; new treatment guideline for diabetes; new pertussis vaccine recommendation; antibiotics and rhinosinusitis; fluoroquinolones and cystitis; and FDA actions.